Timothy Rothwell on board as VP-marketing and sales effective June 24 from Bristol-Myers Squibb. He succeeds Peter Reckert who has left the company. Rothwell was VP and manager of Squibb's U.S. Pharmaceutical Division from 1989-1991. From 1972 to 1989, he worked for Sandoz in a variety of legal and management positions, and was named chief operating officer of the pharmaceutical operations in 1988.
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth